Novartis
Forbes Global 2000 1996 #101 by revenue Switzerland Healthcare Drugs & Biotechnology novartis.com
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products.
Forbes Global 2000's description, shown to identify the company. We rate the name, not the business.
- Evocativity EVOC : red
- New-art roots do not clearly identify medicine
- Brevity BREV : yellow
- 8 letters, 3 syllables. Up to seven letters is green, eight at two syllables too; up to ten yellow, eleven or more red.
- Greppability GREP : green
- Found inside 0 other dictionary words.
- Googlability GOOG : green
- Distinctive coined whole
- Pronounceability PRON : green
- No-var-tis follows clear syllables
- Spellability SPEL : yellow
- Novartis versus Novartus is uncertain by ear
- Verbability VERB : red
- No natural medicine action sense
- Nominology
- 70
- All seven dimensions and .com ownership, weighted as set out on Methodology.
- Fluency
- 80
- Brevity and pronounceability only: the subset with published outcome evidence behind it.
- PG grade
- 3 / 4
- Graham's own four-step ladder.
- Exact .com
- Owned
- Shape
- invented
- Length
- 8 chars, 3 syllables
- Distinctiveness
- fanciful
Rubric version 2026.10.20-1, judged by gpt-6.1-sol (agent).
This scores the name only. See Methodology.
These judged dimensions came from an AI agent working through the judging queue in a chat, on the same rubric the scoring pipeline sends. The agent passed the calibration exam before its work was accepted, and each batch it judged hid two names with known answers as a check. The model is named as the agent reported it.